Please wait...
About This Project
We have invented a Nanocarrier that targets the Immune System to deliver Curcumin, an anti-inflammatory agent, to the brain for the treatment of neurodegenerative diseases, such as Chronic Traumatic Encephalopathy.
Our preclinical study at Charles River Labs and the U. of Arizona, is being conducted to establish proof of effective nanocarrier delivery of Curcumin to the cells of the brain damaged by repeated traumatic athletic injuries to the head.
Recent Lab Notes From This Project

Browse Other Projects on Experiment
Related Projects
Are coyotes contributing to the spread Rocky Mountain spotted fever in Arizona?
Rocky Mountain spotted fever (RMSF) is a tick-borne bacterial infection that can cause permanent disability...
Comprehensive health assessment of gopher tortoises inhabiting fragmented habitat in South Florida
Low fecundity has been reported for many gopher tortoise (Gopherus polyphemus) aggregations in south Florida...
Target-based drug discovery for coronavirus disease 2019
Therapeutics in any modality to combat Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infections...